These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 22882693)

  • 41. Risk factors for carbapenem-resistant Klebsiella pneumoniae infection/colonization: a case-case-control study.
    Kofteridis DP; Valachis A; Dimopoulou D; Maraki S; Christidou A; Mantadakis E; Samonis G
    J Infect Chemother; 2014 May; 20(5):293-7. PubMed ID: 24703709
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Risk factors for carbapenem-resistant Klebsiella pneumoniae infection/colonization and predictors of mortality: a retrospective study.
    Jiao Y; Qin Y; Liu J; Li Q; Dong Y; Shang Y; Huang Y; Liu R
    Pathog Glob Health; 2015 Mar; 109(2):68-74. PubMed ID: 25707874
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Carbapenem-resistant Klebsiella pneumoniae bacteremia: factors correlated with clinical and microbiologic outcomes.
    Nguyen M; Eschenauer GA; Bryan M; O'Neil K; Furuya EY; Della-Latta P; Kubin CJ
    Diagn Microbiol Infect Dis; 2010 Jun; 67(2):180-4. PubMed ID: 20356699
    [TBL] [Abstract][Full Text] [Related]  

  • 44. In vitro activities of 16 antimicrobial agents against clinical isolates of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in two regional hospitals in Taiwan.
    Liao CH; Sheng WH; Wang JT; Sun HY; Wang HK; Hsueh PR; Chen YC; Chang SC
    J Microbiol Immunol Infect; 2006 Feb; 39(1):59-66. PubMed ID: 16440125
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Antibiotic therapy for Klebsiella pneumoniae bacteremia: implications of production of extended-spectrum beta-lactamases.
    Paterson DL; Ko WC; Von Gottberg A; Mohapatra S; Casellas JM; Goossens H; Mulazimoglu L; Trenholme G; Klugman KP; Bonomo RA; Rice LB; Wagener MM; McCormack JG; Yu VL
    Clin Infect Dis; 2004 Jul; 39(1):31-7. PubMed ID: 15206050
    [TBL] [Abstract][Full Text] [Related]  

  • 46. An outbreak of SHV-5 producing Klebsiella pneumoniae in a neonatal intensive care unit; meropenem failed to avoid fecal colonization.
    Gundes S; Arisoy AE; Kolayli F; Karaali E; Turker G; Sanic A; Arisoy ES; Vahaboglu H
    New Microbiol; 2005 Jul; 28(3):231-6. PubMed ID: 16240695
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Bloodstream infections caused by carbapenemase-producing Klebsiella pneumoniae among intensive care unit patients after orthotopic liver transplantation: risk factors for infection and impact of resistance on outcomes.
    Mouloudi E; Massa E; Papadopoulos S; Iosifidis E; Roilides I; Theodoridou T; Piperidou M; Orphanou A; Passakiotou M; Imvrios G; Fouzas I; Papanikolaou V; Gritsi-Gerogianni N
    Transplant Proc; 2014 Nov; 46(9):3216-8. PubMed ID: 25420863
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Risk factors for the acquisition of nosocomial infection with carbapenem-resistant Klebsiella pneumoniae.
    Wu D; Cai J; Liu J
    South Med J; 2011 Feb; 104(2):106-10. PubMed ID: 21258230
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Organ transplantation from a donor colonized with a multidrug-resistant organism: a case report.
    Goldberg E; Bishara J; Lev S; Singer P; Cohen J
    Transpl Infect Dis; 2012 Jun; 14(3):296-9. PubMed ID: 22176504
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Bloodstream infections among carriers of carbapenem-resistant Klebsiella pneumoniae: etiology, incidence and predictors.
    Amit S; Mishali H; Kotlovsky T; Schwaber MJ; Carmeli Y
    Clin Microbiol Infect; 2015 Jan; 21(1):30-4. PubMed ID: 25636924
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Recovery of ceftazidime-resistant Klebsiella pneumoniae from pediatric liver and intestinal transplant recipients.
    Green M; Barbadora K
    Pediatr Transplant; 1998 Aug; 2(3):224-30. PubMed ID: 10084747
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Risk factors and clinical significance of ertapenem-resistant Klebsiella pneumoniae in hospitalised patients.
    Orsi GB; García-Fernández A; Giordano A; Venditti C; Bencardino A; Gianfreda R; Falcone M; Carattoli A; Venditti M
    J Hosp Infect; 2011 May; 78(1):54-8. PubMed ID: 21450365
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Carriage rate of carbapenem-resistant Klebsiella pneumoniae in hospitalised patients during a national outbreak.
    Wiener-Well Y; Rudensky B; Yinnon AM; Kopuit P; Schlesinger Y; Broide E; Lachish T; Raveh D
    J Hosp Infect; 2010 Apr; 74(4):344-9. PubMed ID: 19783067
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Risk factors and outcomes of carbapenem-resistant Klebsiella pneumoniae infections in liver transplant recipients.
    Pereira MR; Scully BF; Pouch SM; Uhlemann AC; Goudie S; Emond JE; Verna EC
    Liver Transpl; 2015 Dec; 21(12):1511-9. PubMed ID: 26136397
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Extended-spectrum beta-lactamase-producing Klebsiella pneumoniae hospital acquired bacteremia. Risk factors and clinical outcome.
    Panhotra BR; Saxena AK; Al-Ghamdi AM
    Saudi Med J; 2004 Dec; 25(12):1871-6. PubMed ID: 15711657
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A multifaceted intervention strategy for eradication of a hospital-wide outbreak caused by carbapenem-resistant Klebsiella pneumoniae in Southern Israel.
    Borer A; Eskira S; Nativ R; Saidel-Odes L; Riesenberg K; Livshiz-Riven I; Schlaeffer F; Sherf M; Peled N
    Infect Control Hosp Epidemiol; 2011 Dec; 32(12):1158-65. PubMed ID: 22080653
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Evaluation of risk factors for the acquisition of bloodstream infections with extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella species in the intensive care unit; antibiotic management and clinical outcome.
    Cordery RJ; Roberts CH; Cooper SJ; Bellinghan G; Shetty N
    J Hosp Infect; 2008 Feb; 68(2):108-15. PubMed ID: 18063198
    [TBL] [Abstract][Full Text] [Related]  

  • 58. SCT in patients with carbapenem resistant Klebsiella pneumoniae: a single center experience with oral gentamicin for the eradication of carrier state.
    Zuckerman T; Benyamini N; Sprecher H; Fineman R; Finkelstein R; Rowe JM; Oren I
    Bone Marrow Transplant; 2011 Sep; 46(9):1226-30. PubMed ID: 21057549
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Klebsiella pneumoniae infection in solid organ transplant recipients: epidemiology and antibiotic resistance.
    Linares L; Cervera C; Hoyo I; Sanclemente G; Marco F; Cofán F; Ricart MJ; Navasa M; Moreno A
    Transplant Proc; 2010 Oct; 42(8):2941-3. PubMed ID: 20970577
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Extended spectrum beta lactamase producing Escherichia coli and Klebsiella pneumoniae: risk factors for infection and impact of resistance on outcomes.
    Shanthi M; Sekar U
    J Assoc Physicians India; 2010 Dec; 58 Suppl():41-4. PubMed ID: 21568008
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.